Related Experiment Video

Updated: May 14, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms

Zhen Lu1, Robert C Bast

  • 1Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Cell Adhesion & Migration
|January 30, 2013
PubMed

Insights

The tumor suppressor gene ARHI (abundant early growth response gene 1) inhibits ovarian cancer cell migration and invasion. Its re-expression halts tumor growth, induces dormancy, and impacts key signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The imprinted tumor suppressor gene ARHI is downregulated in over 60% of ovarian cancers, correlating with reduced progression-free survival.
  • ARHI encodes a Ras-homologous GTPase crucial for regulating cell behavior.
  • Re-expression of ARHI has demonstrated potent anti-tumorigenic effects, including growth inhibition, autophagy induction, and tumor dormancy.

Discussion:

  • ARHI re-expression significantly impedes ovarian cancer cell migration, affecting both chemotaxis and haptotaxis.
  • It achieves this by sequestering STAT3 in the cytoplasm, preventing nuclear translocation and focal adhesion localization.
  • ARHI disrupts focal adhesions and FAK-mediated RhoA signaling, inhibiting actin stress fiber formation and decreasing GTP-RhoA levels.

Key Insights:

  • ARHI's role in suppressing ovarian cancer cell motility is multifaceted, involving STAT3 regulation and focal adhesion disruption.
  • Inhibition of FAK phosphorylation and RhoA signaling are critical mechanisms by which ARHI suppresses migration.
  • Decreased expression of β-1 integrin due to ARHI re-expression may further contribute to reduced migration, adhesion, and invasion.

Outlook:

  • Further investigation into ARHI's regulatory mechanisms could reveal novel therapeutic targets for ovarian cancer.
  • Understanding ARHI's impact on signaling pathways offers potential for developing strategies to restore its tumor-suppressive functions.
  • Targeting ARHI-mediated pathways may enhance treatment efficacy and improve patient outcomes in ovarian cancer.
Keywords:
RhoA GTPaseSTAT3cytoskeletonintegrinmigration suppressiontumor suppressor gene ARHI

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...